Dr. Samuel Rosner, a thoracic oncologist at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, said a growing number of people, particularly women under 65, are ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment ...

Prior to her life altering diagnosis, the preschool teacher, from Newcastle, New South Wales, described herself as 'healthy' and 'fit' with an active lifestyle.

In a previous study, we found that CTC levels decreased after resection in all patients with resectable lung cancer, with those who relapsed ... All patients underwent comprehensive tumor staging with ...

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...

It started with a dull ache in my right shoulder. At first, I chalked it up to bad posture or sleeping funny. Then came a ...

as well as limited-stage small cell lung cancer (SCLC). You may have no symptoms in these early stages of lung cancer, but early signs to watch out for include chest pain, a persistent cough, bloody ...

ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

Still, the therapies’ modest benefit as a maintenance therapy points to how better treatments are needed for small cell lung ...

Patients with extensive-stage SCLC often respond to induction therapy, but the disease tends to progress rapidly after cytotoxic therapy ends, said Jared Weiss, MD, of the University of North Carolina ...

Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...